Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | acetylcholinesterase (Yt blood group) | Starlite/ChEMBL | References |
Bos taurus | Acetylcholinesterase | Starlite/ChEMBL | References |
Homo sapiens | butyrylcholinesterase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | serine/threonine-protein kinase a, putative | 0.0547 | 0 | 0.5 |
Echinococcus granulosus | Glutaredoxin protein 5 | 1.0342 | 0.6272 | 0.9004 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 1.0342 | 0.6272 | 0.9004 |
Entamoeba histolytica | protein kinase, putative | 1.6165 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.5392 | 0.3102 | 0.3102 |
Echinococcus multilocularis | nervana 2 | 1.0342 | 0.6272 | 0.9004 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 1.6165 | 1 | 1 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 1.5734 | 0.9724 | 0.96 |
Trichomonas vaginalis | serine/threonine-protein kinase sgk, putative | 0.5276 | 0.3027 | 0.3027 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 1.0889 | 0.6622 | 0.6622 |
Echinococcus multilocularis | rac serine:threonine kinase | 1.0889 | 0.6622 | 1 |
Echinococcus granulosus | nervana 2 | 1.0342 | 0.6272 | 0.9004 |
Leishmania major | folate/biopterin transporter, putative | 0.0547 | 0 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.5392 | 0.3102 | 0.3102 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 1.6165 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Echinococcus granulosus | serine/threonine protein kinase | 1.0889 | 0.6622 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 1.0889 | 0.6622 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 1.0342 | 0.6272 | 0.9004 |
Echinococcus granulosus | nervana 2 | 1.0342 | 0.6272 | 0.9004 |
Schistosoma mansoni | serine/threonine-protein kinase | 1.0889 | 0.6622 | 1 |
Leishmania major | protein kinase, putative | 0.0547 | 0 | 0.5 |
Echinococcus multilocularis | nervana 2 | 1.0342 | 0.6272 | 0.9004 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.5823 | 0.3378 | 0.3378 |
Entamoeba histolytica | protein kinase, putative | 1.6165 | 1 | 1 |
Giardia lamblia | Kinase, AGC PKA | 1.0458 | 0.6346 | 0.5 |
Echinococcus granulosus | serine threonine protein kinase nrc | 1.0458 | 0.6346 | 0.9216 |
Leishmania major | protein kinase, putative,serine/threonine protein kinase, putative | 0.0547 | 0 | 0.5 |
Trypanosoma cruzi | Protein kinase B | 1.0889 | 0.6622 | 1 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 1.0458 | 0.6346 | 1 |
Toxoplasma gondii | AGC kinase | 1.5734 | 0.9724 | 1 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 1.0458 | 0.6346 | 1 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 1.0458 | 0.6346 | 0.9583 |
Trichomonas vaginalis | AGC family protein kinase | 1.6165 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.5392 | 0.3102 | 0.3102 |
Leishmania major | rac serine-threonine kinase, putative,protein kinase, putative | 0.0547 | 0 | 0.5 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 1.0889 | 0.6622 | 1 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 1.0342 | 0.6272 | 0.9004 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 1.0458 | 0.6346 | 0.9216 |
Entamoeba histolytica | protein kinase 2, putative | 1.0458 | 0.6346 | 0.6346 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 1.0889 | 0.6622 | 0.6622 |
Leishmania major | protein kinase, putative | 0.0547 | 0 | 0.5 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 1.0458 | 0.6346 | 0.9216 |
Trichomonas vaginalis | AGC family protein kinase | 0.5392 | 0.3102 | 0.3102 |
Brugia malayi | p70 ribosomal S6 kinase beta | 1.5734 | 0.9724 | 0.96 |
Entamoeba histolytica | protein kinase, putative | 1.5734 | 0.9724 | 0.9724 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AI50 (functional) | = 8 | Compound was evaluated for the antagonism index | ChEMBL. | 11101357 |
AI50 (functional) | 0 nM | Drug concentration that reaches 50% of antagonism index (AI); Not determined | ChEMBL. | 10464010 |
AI50 (functional) | = 8 nM | Drug concentration that reaches 50% of antagonism index (AI). | ChEMBL. | 10464010 |
AI50 (functional) | = 48.6 nM | Drug concentration that reaches 50% of antagonism index (AI). | ChEMBL. | 10464010 |
Fold IC50 (binding) | ~ 15 | Inhibitory activity of the compound against acetylcholinesterase compared to the IC50 of (-)-9M-HTH | ChEMBL. | 10602696 |
IC50 (binding) | = -8.46 | In vitro inhibitory activity against bovine acetylcholinesterase | ChEMBL. | 15317459 |
IC50 (binding) | = 3.49 nM | Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes | ChEMBL. | 10464010 |
IC50 (binding) | = 3.49 nM | Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes | ChEMBL. | 10464010 |
IC50 (binding) | = 3.49 nM | Inhibition of bovine erythrocyte AChE | ChEMBL. | 17154513 |
IC50 (binding) | = 4.58 nM | Inhibition of acetylcholinesterase isolated from Human erythrocytes. | ChEMBL. | 11101357 |
IC50 (binding) | = 4.58 nM | Inhibition of acetylcholinesterase isolated from Human erythrocytes. | ChEMBL. | 11101357 |
IC50 (binding) | = 8.5 nM | Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes | ChEMBL. | 10464010 |
IC50 (binding) | = 8.5 nM | Compound was evaluated for the inhibition of acetylcholinesterase of bovine erythrocytes | ChEMBL. | 11101357 |
IC50 (binding) | = 8.5 nM | Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes | ChEMBL. | 10464010 |
IC50 (binding) | = 8.5 nM | Compound was evaluated for the inhibition of acetylcholinesterase of bovine erythrocytes | ChEMBL. | 11101357 |
IC50 (binding) | = 8.51 nM | Inhibition of bovine erythrocyte AChE | ChEMBL. | 17154513 |
IC50 (binding) | = 138 nM | Inhibition of butyrylcholinesterase (BChE) activity in human serum | ChEMBL. | 10464010 |
IC50 (binding) | = 138 nM | Inhibition of butyrylcholinesterase (BChE) activity in human serum | ChEMBL. | 10464010 |
IC50 (binding) | = 197 nM | Inhibition of butyrylcholinesterase (BChE) activity in human serum | ChEMBL. | 10464010 |
IC50 (binding) | = 197 nM | Inhibition of butyrylcholinesterase (BChE) in human serum | ChEMBL. | 11101357 |
IC50 (binding) | = 197 nM | Inhibition of butyrylcholinesterase (BChE) activity in human serum | ChEMBL. | 10464010 |
IC50 (binding) | = 197 nM | Inhibition of butyrylcholinesterase (BChE) in human serum | ChEMBL. | 11101357 |
IC50 (binding) | = 1480 nM | Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes | ChEMBL. | 10464010 |
IC50 (binding) | = 1480 nM | Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes | ChEMBL. | 10464010 |
IC50 (binding) | = 2930 nM | Inhibition of butyrylcholinesterase (BChE) activity in human serum | ChEMBL. | 10464010 |
IC50 (binding) | = 2930 nM | Inhibition of butyrylcholinesterase (BChE) activity in human serum | ChEMBL. | 10464010 |
Ratio (binding) | = 1.86 | Ratio between IC50 of bovine AChE and human AChE | ChEMBL. | 11101357 |
Ratio (binding) | = 2 | Inhibition ratio, (IC50 for human BChE activity) / (IC50 for bovine AChE activity) | ChEMBL. | 10464010 |
Ratio (binding) | = 23 | Inhibition ratio, (IC50 for human BChE activity) / (IC50 for bovine AChE activity) | ChEMBL. | 10464010 |
Ratio (binding) | = 40 | Inhibition ratio, (IC50 for human BChE activity) / (IC50 for bovine AChE activity) | ChEMBL. | 10464010 |
Ratio (binding) | = 43 | Ratio between IC50 of human BChE and human AChE | ChEMBL. | 11101357 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.